Hoffmann, K; Ganten, T; Glimm, H; Radeleff, B; von Kalle, C; Jager, D; Buchler, MW; Schemmer, P.
Sorafenib in patients with hepatocellular cancer before liver transplantation - first safety data of the prospective, randomized, double-blind, multi-center, phase III HeiLivCa trial [ISRCTN24081794]
CANCER RES. 2011; 71:
Doi: 10.1158/1538-7445.AM2011-2246
Web of Science
FullText
FullText_MUG